Absorption prediction from physicochemical parameters

Pharmaceutical Science and Technology Today

Volumn 2, Issue 9, 1999, Pages 373-380

  Krämer, Stefanie D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; NEW DRUG;

BLOOD BRAIN BARRIER; CELL STRAIN CACO 2; CHROMATOGRAPHY; DRUG ABSORPTION; ELECTRICITY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; LIPOPHILICITY; MEMBRANE PERMEABILITY; MODEL; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PREDICTION; REVIEW;

EID: 0033199346     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(99)00188-1     Document Type: Review

References (44)

1. 1 Meyer, H. (1899) Arch. Exp. Path. Pharmakol. 42, 109-118
2. 2 Overton, E. (1896) Z. Phys. Chem. 22, 189-209
3. 3 Mitic, L.L. and Anderson, J.M. (1998) Annu. Rev. Physiol. 60, 121-142
4. 4 Lennernäs, H. (1995) Pharm. Res. 12, 1573-1582
5. 5 Artrusson, P., Ungell, A.L. and Löfroth, J.E. (1993) Pharm. Res. 10, 1123-1129
6. 6 Hunter, J., Hirst, B.H. and Simmons, N.L. (1993) Pharm. Res. 10, 743-749
7. 7 Schinkel, A.H. et al. (1995) J. Clin. Invest. 96, 1698-1705
8. 8 Artursson, P., Palm, K. and Luthman, K. (1996) Adv. Drug. Deliv. Rev. 22, 67-84
9. 9 Nernst, W. (1891) Z. Phys. Chem. 8, 110-139
10. 10 Hansch, C. and Leo, A.J. (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley Interscience, New York, NY, USA
11. 11 Avdeef, A. (1993) J. Pharm. Sci. 82, 183-190
12. 12 Camenisch, G. et al. (1998) Eur. J. Pharm. Sci. 6, 313-319
13. 13 Camenisch, G., Folkers, G. and van de Waterbeemd, H. (1996) Pharm. Acta Helv. 71, 309-327
14. 14 Dressman, J.B., Amidon, G.L. and Fleisher, D. (1985) J. Pharm. Sci. 74, 588-589
15. 15 van de Waterbeemd, H. and Mannhold, R. (1996) Quant. Struct.-Act. Relatsh. 15, 410-412
16. 16 Rekker, R.F. and De Kort, H.M. (1979) Eur. J. Med. Chem.-Chim. Ther. 14, 479-488
17. 17 Broto, P., Moreau, G. and Vandycke, C. (1984) Eur. J. Med. Chem.-Chim. Ther. 19, 71-78
18. 18 Ghose, A.K. and Crippen, G.M. (1986) J. Comput. Chem. 7, 565-577
19. 19 Seiler, P. (1974) Eur. J. Med. Chem. 9, 473-479
20. 20 Young, R.C. et al. (1988) J. Med. Chem. 31, 656-671
21. 21 van de Waterbeemd, H. and Kansy, M. (1992) Chimia 46, 299-303
22. 22 El Tayar, N. et al. (1991) J. Pharm. Sci. 80, 744-749
23. 23 Ter Laak, A.M. et al. (1994) Eur. J. Pharm. Sci. 2, 373-384
24. 24 Sugawara, M. (1998) J. Pharm. Sci. 87, 960-966
25. 25 Balon, K., Riebesehl, B.U. and Müller, B.W (1999) Pharm. Res. 16, 890-896
26. 26 Avdeef, A. (1998) Pharm. Res. 15, 209-215
27. 27 Krämer, S.D. and Wunderli-Allenspach, H. (1996) Pharm. Res. 13, 1851-1855
28. 28 Krämer, S.D., Jakits-Deiser, C. and Wunderli-Allenspach, H. (1997) Pharm. Res. 14, 827-832
29. 29 Krämer, S.D. et al. (1998) Pharm. Res. 15, 739-744
30. 30 Beigi, F. et al. (1998) Int. J. Pharm. 164, 129-137
31. 31 Ong, S., Liu, H. and Pidgeon, C. (1996) J. Chromatogr. A 728, 113-128
32. 32 Ottiger, C. and Wunderli-Allenspach, H. (1999) Pharm. Res. 16, 643-650
33. 33 Abraham, M.H. and Chadha, H.S. (1996) Lipophilicity in Drug Action and Toxicology (Pliska, V., Testa, B. and van de Waterbeemd, H., eds), pp. 311-337, VCH, Weinheim, Germany
34. 34 Abraham, M.H., Chadha, H.S. and Mitchell, R.C. (1994) J. Pharm. Sci. 83, 1257-1268
35. 35 Abraham, M.H., Chadha, H.S. and Mitchell, R.C. (1995) J. Pharm. Pharmacol. 47, 8-16
36. 36 Abraham, M.H., Martins, F. and Mitchell, R.C. (1997) J. Pharm. Pharmacol. 49, 858-865
37. 37 Gratton, J.A. et al. (1997) J. Pharm. Pharmacol. 49, 1211-1216
38. 38 Palm, K. et al. (1997) Pharm. Res. 14, 568-571
39. 39 Krarup, L.H. et al. (1998) Pharm. Res. 15, 972-978
40. 40 Lipinski, C.A. et al. (1997) Adv. Drug. Deliv. Rev. 23, 3-25
41. 41 Wessel, M.D. et al. (1998) J. Chem. Inf. Comput. Sci. 38, 726-735
42. 42 Norinder, U., Österberg, T. and Artursson, P. (1997) Pharm. Res. 14, 1786-1791
43. 43 Grès, M.C. et al. (1998) Pharm. Res. 15, 726-733
44. 44 Artursson, P. and Karlsson, J. (1991) Biochem. Biophys. Res. Commun. 175, 880-885